Siemens Healthineers, with over 125 years of experience, is a leading global medical technology company dedicated to pioneering breakthroughs in healthcare. Their comprehensive portfolio encompasses medical imaging, laboratory diagnostics, point-of-care testing, and advanced therapies, including image-guided therapy and cancer care solutions. Emphasizing innovation and sustainability, Siemens Healthineers integrates artificial intelligence and digital health solutions to enhance patient outcomes and optimize clinical workflows. With a presence in over 70 countries, they serve healthcare providers worldwide, addressing challenges across various medical disciplines.
The company will discontinue general imaging ultrasound sales, prioritizing cardiovascular interventions, intracardiac echocardiography, software and AI.
Siemens Healthineers launches the Innovance D-Dimer 2.0 assay to enhance diagnostic evaluation and workflow efficiency for venous thromboembolism and hypercoagulable conditions.
Siemens Healthineers introduces Accela, a software-driven radiotherapy solution engineered around dynamic modulated arc therapy to scale complex cancer treatments.
The organizations are expanding their 35-year partnership to foster clinical innovation, enhance patient care, and streamline operations across the health system.
Siemens Healthineers and Vanderbilt Health have established an 87 million dollar partnership to standardize diagnostic imaging and radiation oncology systems across medical facilities.
Cercare Medical and Siemens Healthineers are collaborating to accelerate the global adoption of Cone-Beam CT Perfusion technology in acute stroke care.